1. Home
  2. GOCO vs VNRX Comparison

GOCO vs VNRX Comparison

Compare GOCO & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GoHealth Inc.

GOCO

GoHealth Inc.

HOLD

Current Price

$1.57

Market Cap

38.3M

Sector

Finance

ML Signal

HOLD

Logo VolitionRX Limited

VNRX

VolitionRX Limited

HOLD

Current Price

$0.20

Market Cap

31.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GOCO
VNRX
Founded
2001
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Specialty Insurers
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
38.3M
31.9M
IPO Year
2020
2012

Fundamental Metrics

Financial Performance
Metric
GOCO
VNRX
Price
$1.57
$0.20
Analyst Decision
Hold
Strong Buy
Analyst Count
2
4
Target Price
$5.00
$2.50
AVG Volume (30 Days)
34.1K
1.9M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
90.82
38.00
EPS
N/A
N/A
Revenue
$798,894,000.00
$1,233,511.00
Revenue This Year
N/A
$60.84
Revenue Next Year
N/A
$404.89
P/E Ratio
N/A
N/A
Revenue Growth
8.74
59.10
52 Week Low
$1.31
$0.17
52 Week High
$16.40
$0.94

Technical Indicators

Market Signals
Indicator
GOCO
VNRX
Relative Strength Index (RSI) 40.08 38.64
Support Level N/A $0.17
Resistance Level $2.56 $0.33
Average True Range (ATR) 0.13 0.02
MACD -0.00 0.00
Stochastic Oscillator 37.14 33.37

Price Performance

Historical Comparison
GOCO
VNRX

About GOCO GoHealth Inc.

GoHealth Inc is a health insurance marketplace and Medicare-focused digital health company whose purpose is to compassionately ensure consumers' peace of mind when making healthcare decisions so consumers can focus on living life. It offers Medicare plans, including, but not limited to, Medicare Advantage, Medicare Supplement and prescription drug plans. Its proprietary technology platform leverages modern machine-learning algorithms, powered by over two decades of insurance purchasing behavior, to reimagine the process of matching a health plan to a consumer's specific needs.

About VNRX VolitionRX Limited

VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.

Share on Social Networks: